Medicine and Dentistry
Macular Edema
55%
Uveitis
54%
Pars Plana Vitrectomy
43%
Macular Hole
37%
Visual Acuity
34%
ST Segment Elevation Myocardial Infarction
34%
Adverse Event
33%
Clinical Trial
31%
Triamcinolone Acetonide
31%
Diseases
30%
Fluorescein Angiography
29%
Cataract
25%
Bevacizumab
23%
Spectral Domain Optical Coherence Tomography
23%
Diabetic Retinopathy
23%
Intravitreal Administration
23%
Retinal Detachment
19%
Systematic Review
19%
Best Corrected Visual Acuity
18%
Percutaneous Coronary Intervention
18%
Intraocular Pressure
18%
Retinal Disease
17%
LASIK
17%
Meta-Analysis
17%
Vitrectomy
17%
Aflibercept
17%
Birdshot Chorioretinopathy
17%
Phakomatosis
17%
Intraocular Lens
17%
Choroidal Disease
17%
Coats' Disease
17%
Proliferative Diabetic Retinopathy
17%
Rapamycin
17%
Corticosteroid
17%
Foreign Body
17%
Indocyanine Green Angiography
17%
Diagnosis
17%
Juvenile Xanthogranuloma
17%
Post-Hoc Analysis
17%
Bacterial Keratitis
17%
Retina Tear
17%
Cataract Surgery
17%
Susac Syndrome
17%
Hazard Ratio
14%
Arm
12%
Intraocular Drug Administration
12%
Corneal Ulcer
12%
Diabetic Macular Edema
11%
Recurrent Disease
11%
Hearing Impairment
11%
Keyphrases
Suprachoroidal
69%
Macular Edema
51%
CLS-TA
34%
Non-infectious Uveitis
32%
Triamcinolone Acetonide
29%
Uveitic Macular Edema
27%
Spectral Domain Optical Coherence Tomography (SD-OCT)
24%
Best-corrected Visual Acuity
22%
Early Treatment Diabetic Retinopathy Study
21%
Randomized Phase III Trial
20%
Clinical Trials
20%
Central Subfield Thickness
19%
Adverse Events
17%
Power Selection
17%
Intraocular Lens Power
17%
New Association
17%
Intracorneal
17%
Corneal Suture
17%
Moderate to Severe
17%
Delayed-onset Endophthalmitis
17%
Long-term Mortality
17%
Corticosteroid Injection
17%
Injectable Suspension
17%
Gauge Systems
17%
Hydrophobic Acrylic
17%
Scleral Fixated
17%
Choroidal Disease
17%
Pediatric Retinal Diseases
17%
Coats Disease
17%
Needle Length
17%
Microinjector
17%
Timely Access
17%
Regional System
17%
Systemic Corticosteroids
17%
RECOVERY Trial
17%
Carbon Monoxide Poisoning
17%
Phase II Study
17%
Phacomatosis pigmentovascularis
17%
Radiation Dose Management
17%
Lead Shielding
17%
Cath Lab
17%
Expansile Gas
17%
Myocardial Injury
17%
Steroid-sparing
17%
Early Adoption
17%
Sham Control
12%
Serious Adverse Events
11%
Inclusion Criteria
11%
Gore-Tex Suture
10%
Suprachoroidal Injection
9%
Pharmacology, Toxicology and Pharmaceutical Science
Uveitis
100%
Macular Edema
92%
Triamcinolone Acetonide
66%
Diabetic Retinopathy
48%
Diseases
44%
Adverse Event
39%
Aflibercept
34%
Proliferative Diabetic Retinopathy
34%
Carbon Monoxide Poisoning
34%
Clinical Trial
17%
Bevacizumab
17%
Ulcer
17%
Bacterial Keratitis
17%
Juvenile Xanthogranuloma
17%
Heart Muscle Injury
17%
Diabetic Macular Edema
14%
Topical Corticosteroid
13%
Implant
11%
Retina Vein Occlusion
8%
Visual Impairment
7%
Retina Macula Cystoid Edema
7%
Pharmacotherapy
7%
Antibiotics
6%
Side Effect
6%
Cataractogenesis
6%
Randomized Clinical Trial
5%
Vitreoretinopathy
5%
Exudative Retinitis
5%
Chronicity
5%
Intravitreal Administration
5%